Inhibitory effect of a long-acting somatostatin analogue on EGF- stimulated cell proliferation in Capan-2 cells

Journal of Physiology Paris

Volumn 94, Issue 1, 2000, Pages 57-62

  Burghardt, Beáta ^a   Barabás, Kornélia ^a   Marcsek, Zoltán ^a   Flautner, Lajos ^b   Gress, Thomas M ^c   Varga, Gábor ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Capan 2; CCK; Cell division; Pancreas; Receptor; Somatostatin; Subtypes

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

CANCER CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HORMONE ACTION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034075847     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(99)00102-3     Document Type: Conference Paper

References (43)

1. Alumets J., Sundler F., Hakanson R. Distribution, ontogeny and ultrastructure of somatostatin-immunoreactive cells in the pancreas and gut. Cell Tissue Res. 185:1977;165-179.
2. Baldwin G.S. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J. Gastroenterol. Hepatol. 10:1995;215-232.
3. Bloom S.R., Mortimer C.H., Thorner M.O., Besser G.M., Hall R., Gomez-Pan A., Roy V.M., Russel R.C.G., Coy D.H., Kastin A.J., Schally A.V. Inhibition of gastrin and gastric-acid secretion by growth hormone-inhibiting hormone. Lancet. 2:1974;1106-1109.
4. Brodish R.J., Kuvshinoff B.W., McFadden D.W., Fink A.S. Somatostatin inhibits cholecystokinin-induced pancreatic protein secretion via cholinergic pathways. Pancreas. 4:1995;401-406.
5. Bruno J.F., Xu Y., Song J., Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology. 133:1993;2561-2567.
6. Bruns C., Weckbecker G., Raulf F., Kaupmann K., Schoeffter P., Hoyer D., Lübbert H. Molecular pharmacology of somatostatin receptor subtypes. Ann. N.Y. Acad. Sci. 733:1994;138-146.
7. Buscail L., Delesque N., Esteve J.P., Saint-Laurent N., Prats H., Clerc P., Robberecht P., Bell G.I., Liebow C., Schally A.V. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA. 91:1994;2315-2319.
8. Buscail L., Esteve J.P., Saint-Laurent N., Bertand V., Reisine T., O'Carroll A.M., Bell G.I., Schally A.V., Vayasse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by sometostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. USA. 92:1995;1580-1584.
9. Buscail L., Saint-Laurent N., Chastre E., Vaillant J.C., Gespach C., Capella G., Kalthoff H., Lluis F., Vayasse N., Susini C. Loss of sst2 somatostatin receptor gene in human pancreatic and colorectal cancer. Cancer Res. 56:1996;1823-1827.
10. Chariot J., Roze C., Vaille C., Debray C. Effects of somatostatin on basal and stimulated pancreatic secretion of the pancreas of the rat. Gastroenterology. 75:1978;832-837.
11. Chey W.Y., et al. Hormonal control of pancreatic exocrine secretion. Go V.W. The Pancreas: Biology, Pathobiology and Disease. 1993;403-423 Raven, New York.
12. Chiba T., Yamada T. Gut somatostatin. Walsh J.H, Dockray G.J. Gut peptides: Biochemistry and Physiology. 1994;123-145 Raven, New York.
13. Chuang C.N., Tanner M., Lloyd K.C.K., Wong H., Soll A.H. Endogenous somatostatin inhibits histamine release from canine mucosal cells in primary culture. Am. J. Physiol. 265:1993;G521-G525.
14. Delesque N., Buscail L., Esteve J.P., Saint-Laurent N., Müller C., Weckbecker G., Burns C., Vayasse N., Susini C. sst2 Somatostatine receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res. 57:1997;956-962.
15. Detjen K., Fenrich M.C., Logsdon C.D. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. Gastroenterology. 112:1997;952-959.
16. Dourish C.T., Hill D.R. Classification and function of CCK receptors. Trends Pharmacol. Sci. 8:1987;207-208.
17. Fisher W.E., Muscarella P., O'Dorsio T.M., O'Dorsio M.S., Kim J.A., Doran T.A., Sabourin C.L., Schrimer W.J. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery. 120:1996;234-240.
18. Frazier M.L., Longnecker D.S., et al. Cell lines of the human and rodent exocrine pancreas. Go V.L.W. The pancreas: biology, pathobiology and disease. 2nd edn :1993;565-573 Raven, New York.
19. Friess H., Büchler M.W., Korc M. Growth factors and growth factor receptors in pancreatic cancer. Neoptolemos J.P, Lemoine N.R. Pancreatic cancer, molecular and clinical advances. 1996;51-60 Blackwell, Oxford.
20. Gress T.M., Müller-Pillasch F., Adler G., Zehetner G., Lehrach H. European Pancreatic Cancer Reference Library System, EPCRLS. Eur. J. Cancer. 9:1994;1391-1394.
21. Lee Y.M., Beinborn M., McBride E.W., Lu M., Kolakowski L.F. Jr., Kopin A.S. The human brain cholecystokinin B/gastrin receptor. Cloning and characterization. J. Biol. Chem. 268:1993;8164-8169.
22. Lewin M.J.M. The somatostatin receptor in the GI tract. Annu. Rev. Physiol. 54:1992;455-468.
23. Liddle R.A. Cholecystokinin. Walsh J.H, Dockray G.J. Gut Peptides: Biochemistry and Physiology. 1994;175-216 Raven, New York.
24. Liebow C., Hierowski M., du Sapin K. Hormonal control of pancreatic cancer growth. Pancreas. 1:1986;44-48.
25. Liebow C., Reilly C., Serrano M., Schally A.V. Somatostatin analogues that inhibit growth of pancreatic cancer by stimulating tyrosin phosphatase. Proc. Natl. Acad. Sci. USA. 86:1989;2003-2007.
26. Liehr R.M., Melnikovych G., Solomon T.E. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. Gastroenterology. 98:1990;1666-1674.
27. Lotti V.J., Chang R.S.L. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365, 260. Eur. J. Pharmacol. 162:1989;273-280.
28. Monstein H.J., Nylander A.G., Salehi A., Chen D., Lundquist I., Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand. J. Gastroenterol. 31:1996;383-390.
29. Müller-Pillasch F., Lacher U., Wallrapp C., Micha A., Zimmerhackl F., Hameister H., Varga G., Friess H., Büchler M., Villa M.R., Adler G., Gress T.M. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 14:1997;2729-2733.
30. Patel Y.C., Srikant C.B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 135:1994;2814-2817.
31. Reubi J.C., Waser B., Schaer J.C., Markwalder R. Somatostatin receptors in human prostate cancer. J. Clin. Endocrinol. Metab. 80:1995;2806-2814.
32. Robertson J.F.R., Watson S.A., Hardcastle J.D. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer. 63:1995;69-75.
33. Rossowski W.J., Gu Z.F., Akarca U.S., Jensen R.T., Coy D.H. Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release. Peptides. 8:1994;1421-1424.
34. Shiratori K., Watanabe S., Takeuchi T. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and relase of secretin and cholecystokinin in rats. Pancreas. 6:1991;23-30.
35. Singh M. Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancreas. Dig. Dis. Sci. 28:1983;456-468.
36. Smith J.P., Kramer S.T., Solomon T.E. CCK stimulates growth of six human pancreatic cell lines in serum-free medium. Regul. Pept. 32:1991;341-349.
37. Smith J.P., Rickabaugh C.A., McLaughlin P.J., Zagon I.S. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am. J. Physiol. 265:1993;G149-G155.
38. Smith J.P., Solomon T.E., Bagheri S., Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig. Dis. Sci. 35:1990;1377-1384.
39. Tang C., Biemond I., Verspaget H.W., Offerhaus G.J., Lamers C.B. Expression of somatostatin receptors in human pancreatic tumor. Pancreas. 17:1998;80-84.
40. Vaysse N., Buscail L., Seva C., Delesque N., Negre F., Dufresne M., Clerc P., Susini C., Pradayrol L., Fuormy D. Gastrointestinal peptides and receptors in pancreatic cancer. Neoptolemos J.P, Lemoine N.R. Pancreatic cancer, molecular and clinical advances. 1996;61-67 Blackwell, Oxford.
41. Viguerie N., Tahiri-Jouti N., Ayral A.M. Direct inhibitory effects of a somatostatin analog, SMS201-995, on AR4-2J cell proliferation via pertussistoxin sensitive guanosine triphosphate binding protein independent mechanism. Endocrinology. 124:1989;1017-1025.
42. Wallrapp C., Müller-Pillash F., Solinas-Toldo S., Lichter P., Friess H., Büchler M., Fink T., Adler G., Gress T.M. Characterization of a high copy number amplification at 6q24 in pancreatic cancer indentities c-myb as a candidate oncogene. Cancer Res. 57:1997;3135-3139.
43. Weinberg D.S., Ruggeri B., Berber M.T., Biswas S., Miknyocki S., Waldman S.A. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J. Clin. Invest. 100:1997;597-603.